The following stocks had notable activity in their options during the past week(s): $HZNP (11/18): 1,632 FEB14 6.0 strike Calls (stock at $4.47) were purchased for 0.95 or $155,040. Buyer makes money if stock trades north of $6.95 by expiration. $NWBO (11/18): 250 APR14 7.5 strike Calls (stock at $5.71) were sold for 1.05 or […]
Catalyst Watch – Vol. 1, Edition 8 (11/20/13)
Below are current tactical and strategic thoughts on approaching FDA and clinical trial catalysts for select names. Estimates, values and views are as of the date of publishing (or are noted) and are subject to potential future, pre-catalyst revision. Please read the site Disclaimer: Catalyst Watch List – Update: MACK: No change to strategy (see […]
Week’s Option Activity (11/6~11/13)
The following stocks had notable activity in their options during the past week(s): $MACK (11/6): 600 MAR14 2.50 strike (stock at $2.28) Calls were purchased for 0.60 or $36,000 – buyer makes money if stock trades north of $3.10 by expiration. Another trade, 754 DEC 5.0 strike Calls were sold for 0.10 or (small) total […]
Catalyst Watch – Vol. 1, Edition 7 (11/12/13)
Below are current tactical and strategic thoughts on approaching FDA and clinical trial catalysts for select names. Estimates, values and views are as of the date of publishing (or are noted) and are subject to potential future, pre-catalyst revision: Catalyst Watch List – Update: VNDA: The stock is up 80% on better than expected briefing […]
Week’s Option Activity (10/31~11/4)
The following stocks had notable activity in their options during the past week(s): $VNDA (10/31): Lots of activity – we will stick to the bigger trades. 1,000 NOV 4.0 strike Puts were sold (stock at $6.74) to buy 1,000 NOV 11.0 strike Calls for a net debit of 0.65 or $65,000 – buyer makes money […]
Catalyst Watch – Vol. 1, Edition 6 (10/30/13)
Below are current tactical and strategic thoughts on approaching FDA and clinical trial catalysts for select names. Estimates, values and views are as of the date of publishing (or are noted) and are subject to potential future, pre-catalyst revision: Catalyst Watch List – Update: VNDA: The stock has sold off substantially, from $13 to $7, […]
Catalyst Watch – Vol. 1, Edition 5 (10/22/13)
Below are current tactical and strategic thoughts on approaching FDA and clinical trial catalysts for select names. Estimates, values and views are as of the date of publishing (or are noted) and are subject to potential future, pre-catalyst revision: (1) Catalyst Watch List – Updates: VNDA: No change in strategy (See Vol. 1, Edition 2). […]
Week’s Option Activity (10/10~10/16)
The following stocks had notable activity in their options during the past week(s): $XOMA (10/10): 3,000 OCT 5.0 strike Calls were bought (stock at $4.69) for 0.50 or $150,000. This appears to be an opening trade (thus highly speculative given proximity to expiration). Buyer makes money if stock trades above $5.50 by expiration. $PATH (10/10): […]
Catalyst Watch – Vol. 1, Edition 4 (10/11/13)
Below are current tactical and strategic thoughts on approaching FDA and clinical trial catalysts for select names. Estimates, values and views are as of the date of publishing (or are noted) and are subject to potential future, pre-catalyst revision: (1) Catalyst Watch List – Updates: AMRN: Waiting for briefing docs… More to follow on this […]
Week’s Option Activity (9/30~10/4)
The following stocks had notable activity in their options during the past week: $ACHN (10/1): Substantial Call activity (both near and long term dated options). 28,500 JAN15 5.0/(7.5) strike long Call spreads (stock at $2.66) were bought for 0.40 or $1.14 million. Buyer makes money if stock trades north of $5.40 by January 2015 expiration […]
Catalyst Watch – Vol. 1, Edition 3 (10/2/13)
Below are current tactical and strategic thoughts on approaching FDA and clinical trial catalysts for select names. Estimates, values and views are as of the date of publishing (or are noted) and are subject to potential future, pre-catalyst revision: (1) Catalyst Watch List – Updates: AMRN: Stock continues to climb (now at $6.85). No delay […]
Week’s Option Activity (9/23~9/27)
The following stocks had notable activity in their options during the past week(s): $EDAP (9/23): Bullish long term Call buys. 750 FEB14 2.50 strike Calls (stock at $2.68) were bought for 0.60 or $45,000. Also 750 MAY14 2.50 strike Calls were bought for 0.70 or $52,500. For these trades, buyer makes money if the stock […]
Catalyst Watch – Vol. 1, Edition 2 (9/26/13)
Below are current tactical and strategic thoughts on approaching FDA and clinical trial catalysts for select names. Estimates, values and views are as of the date of publishing (or are noted) and are subject to potential future, pre-catalyst revision: (1) Catalyst Watch List – Updates: AMRN: The stock is up slightly ($6.58) from our last […]
Week’s Option Activity (9/16~9/20)
The following stocks had notable activity in their options during the past week: $GERN (9/17): 5,000 OCT 2.00 strike Puts (stock at $2.26) were purchased for 0.14 or $70,000. This appears to be an opening trade where the buyer makes money if the shares trade below $1.86 by expiration. This could also be a long […]
Catalyst Watch – Vol. 1, Edition 1 (9/20/13)
Below are current tactical and strategic thoughts on approaching FDA and clinical trial catalysts for select names. Estimates, values and views are as of the date of publishing (or are noted) and are subject to potential future, pre-catalyst revision: Ticker: VNDA ($13.16) Catalyst: AdCom for Tasimelteon Date/Timing: November 14, 2013 CRG View: Bearish Cash: $151.9m […]
Week’s Option Activity (9/3~9/13)
The following stocks had notable activity in their options during the past week(s): $RPRX (9/3): Several large trades today. First, 1,580 OCT 30.0 strike Calls (stock at $21.14) were bought for 1.20 or $189,600 – buyer makes money if stock trades north of $31.20 by October expiration. Second, what appears to be a SEP ratioed […]
Week’s Option Activity (8/26~8/30)
The following stocks had notable activity in their options during the past week: $IMMU (8/26): Big activity in JAN14 Calls. 1,949 JAN14 5.0 strike Calls (stock at $6.15) were purchased for 1.60 or total cost of $311,840. Buyer makes money as long as stock is greater than $6.60 by JAN14 expiration. Also in a separate […]
Week’s Option Activity (8/19~8/22)
The following stocks had notable activity in their options during the past week: $AMRN (8/19): 5,000 OCT 7.0 strike Calls (stock at $6.00) were sold for 0.87 or $435,000 total proceeds. Seller makes money as long as stock trades below $7.87 by expiration. This trade may also be a current long stockholder selling Calls to […]
